Global Health Unit, GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Corporate Responsibility, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
Int Health. 2020 Dec 22;13(Suppl 1):S39-S43. doi: 10.1093/inthealth/ihaa077.
World Health Assembly Resolution 50.29, adopted in 1997, committed the World Health Organization (WHO) and its member states to eliminate lymphatic filariasis (LF) as a public health problem. In 2000, to support this ambitious goal and the health ministries in the >70 LF-endemic countries, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) was created. The resulting WHO elimination strategy consists of two main components: to stop the spread of infection by interrupting transmission and to alleviate the suffering of affected populations (by controlling morbidity). The GPELF has brought together a broad global partnership of public and private actors, including three pharmaceutical companies with headquarters in three different continents. The medicine donations programmes from GlaxoSmithKline, MSD (trade name of Merck & Co., Kenilworth, NJ, USA) and Eisai have enabled significant achievements during the first 20 y of the GPELF and are positioned to provide essential contributions to the GPELF's goals for the next decade. As we celebrate the progress towards LF elimination during the GPELF's first 20 y, this article reflects on the factors that led to the creation of the three donation programmes, the contributions these programmes have made and some lessons learned along the way. We close by emphasizing our continued commitments to LF elimination and perspectives on the next decade.
世界卫生大会 1997 年通过的第 50.29 号决议承诺世界卫生组织（世卫组织）及其成员国致力于消除淋巴丝虫病（LF）这一公共卫生问题。2000 年，为了支持这一宏伟目标和支持 70 多个淋巴丝虫病流行国家的卫生部，成立了全球消灭淋巴丝虫病规划（GPELF）。由此产生的世卫组织消除战略由两个主要部分组成：通过中断传播来阻止感染的传播，以及通过控制发病率来减轻受影响人群的痛苦。GPELF 汇集了一个广泛的全球公共和私营部门合作伙伴关系，包括三家总部位于三个不同大陆的制药公司。葛兰素史克、默克公司（美国新泽西州肯尼沃斯的 MSD 的商品名）和卫材的药品捐赠方案在 GPELF 的头 20 年取得了重大成就，并有望为 GPELF 未来十年的目标做出重要贡献。在 GPELF 成立 20 周年之际，我们庆祝在消除 LF 方面取得的进展，本文反思了创建这三个捐赠方案的因素、这些方案所做的贡献以及在此过程中吸取的一些经验教训。最后，我们强调我们对消除 LF 的持续承诺以及对未来十年的看法。
